nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—Purpura non-thrombocytopenic—Colchicine—primary biliary cirrhosis	0.105	0.122	CcSEcCtD
Nadolol—ABCB1—Colchicine—primary biliary cirrhosis	0.0474	1	CbGbCtD
Nadolol—Atrioventricular block complete—Chenodeoxycholic acid—primary biliary cirrhosis	0.0365	0.0425	CcSEcCtD
Nadolol—Atrioventricular block complete—Ursodeoxycholic acid—primary biliary cirrhosis	0.0365	0.0425	CcSEcCtD
Nadolol—Cardiomegaly—Chenodeoxycholic acid—primary biliary cirrhosis	0.035	0.0407	CcSEcCtD
Nadolol—Cardiomegaly—Ursodeoxycholic acid—primary biliary cirrhosis	0.035	0.0407	CcSEcCtD
Nadolol—Sleep disturbance—Ursodeoxycholic acid—primary biliary cirrhosis	0.0228	0.0265	CcSEcCtD
Nadolol—Sleep disturbance—Chenodeoxycholic acid—primary biliary cirrhosis	0.0228	0.0265	CcSEcCtD
Nadolol—Hepatic enzyme increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0135	0.0157	CcSEcCtD
Nadolol—Hepatic enzyme increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0135	0.0157	CcSEcCtD
Nadolol—ABCB1—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.0123	0.133	CbGpPWpGaD
Nadolol—Fluid retention—Ursodeoxycholic acid—primary biliary cirrhosis	0.0121	0.0141	CcSEcCtD
Nadolol—Fluid retention—Chenodeoxycholic acid—primary biliary cirrhosis	0.0121	0.0141	CcSEcCtD
Nadolol—Sleep disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0107	0.0124	CcSEcCtD
Nadolol—Sleep disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0107	0.0124	CcSEcCtD
Nadolol—Cardiac failure congestive—Ursodeoxycholic acid—primary biliary cirrhosis	0.0102	0.0119	CcSEcCtD
Nadolol—Cardiac failure congestive—Chenodeoxycholic acid—primary biliary cirrhosis	0.0102	0.0119	CcSEcCtD
Nadolol—Amnesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00986	0.0115	CcSEcCtD
Nadolol—Amnesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00986	0.0115	CcSEcCtD
Nadolol—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00949	0.011	CcSEcCtD
Nadolol—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00949	0.011	CcSEcCtD
Nadolol—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00936	0.101	CbGpPWpGaD
Nadolol—Diplopia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00927	0.0108	CcSEcCtD
Nadolol—Diplopia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00927	0.0108	CcSEcCtD
Nadolol—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.00854	0.00994	CcSEcCtD
Nadolol—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0082	0.00954	CcSEcCtD
Nadolol—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0082	0.00954	CcSEcCtD
Nadolol—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00768	0.00893	CcSEcCtD
Nadolol—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00768	0.00893	CcSEcCtD
Nadolol—Agranulocytosis—Colchicine—primary biliary cirrhosis	0.00742	0.00862	CcSEcCtD
Nadolol—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00729	0.00847	CcSEcCtD
Nadolol—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00729	0.00847	CcSEcCtD
Nadolol—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.00712	0.00828	CcSEcCtD
Nadolol—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.00712	0.00828	CcSEcCtD
Nadolol—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00694	0.00807	CcSEcCtD
Nadolol—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00694	0.00807	CcSEcCtD
Nadolol—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.00685	0.00796	CcSEcCtD
Nadolol—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.00685	0.00796	CcSEcCtD
Nadolol—ABCB1—Abacavir transmembrane transport—ABCG2—primary biliary cirrhosis	0.00639	0.069	CbGpPWpGaD
Nadolol—Alopecia—Colchicine—primary biliary cirrhosis	0.0063	0.00733	CcSEcCtD
Nadolol—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00618	0.00718	CcSEcCtD
Nadolol—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00618	0.00718	CcSEcCtD
Nadolol—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00598	0.00695	CcSEcCtD
Nadolol—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00598	0.00695	CcSEcCtD
Nadolol—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00566	0.00659	CcSEcCtD
Nadolol—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00566	0.00659	CcSEcCtD
Nadolol—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.0055	0.00639	CcSEcCtD
Nadolol—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.0055	0.00639	CcSEcCtD
Nadolol—ABCB1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00516	0.0557	CbGpPWpGaD
Nadolol—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.005	0.00582	CcSEcCtD
Nadolol—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.005	0.00582	CcSEcCtD
Nadolol—Shock—Colchicine—primary biliary cirrhosis	0.00499	0.0058	CcSEcCtD
Nadolol—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.0049	0.0057	CcSEcCtD
Nadolol—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.0049	0.0057	CcSEcCtD
Nadolol—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00487	0.00566	CcSEcCtD
Nadolol—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00487	0.00566	CcSEcCtD
Nadolol—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00482	0.0056	CcSEcCtD
Nadolol—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00482	0.0056	CcSEcCtD
Nadolol—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00475	0.00552	CcSEcCtD
Nadolol—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00475	0.00552	CcSEcCtD
Nadolol—Hypotension—Colchicine—primary biliary cirrhosis	0.00474	0.00551	CcSEcCtD
Nadolol—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00465	0.0054	CcSEcCtD
Nadolol—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00465	0.0054	CcSEcCtD
Nadolol—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00455	0.0053	CcSEcCtD
Nadolol—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00455	0.0053	CcSEcCtD
Nadolol—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00448	0.00521	CcSEcCtD
Nadolol—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00448	0.00521	CcSEcCtD
Nadolol—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00441	0.00512	CcSEcCtD
Nadolol—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0044	0.00512	CcSEcCtD
Nadolol—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0044	0.00512	CcSEcCtD
Nadolol—Fatigue—Colchicine—primary biliary cirrhosis	0.00437	0.00508	CcSEcCtD
Nadolol—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00434	0.00505	CcSEcCtD
Nadolol—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00434	0.00505	CcSEcCtD
Nadolol—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00426	0.00495	CcSEcCtD
Nadolol—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00426	0.00495	CcSEcCtD
Nadolol—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00412	0.00479	CcSEcCtD
Nadolol—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00412	0.00479	CcSEcCtD
Nadolol—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00409	0.00476	CcSEcCtD
Nadolol—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00409	0.00476	CcSEcCtD
Nadolol—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00406	0.00472	CcSEcCtD
Nadolol—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00406	0.00472	CcSEcCtD
Nadolol—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00401	0.00466	CcSEcCtD
Nadolol—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00401	0.00466	CcSEcCtD
Nadolol—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00396	0.0046	CcSEcCtD
Nadolol—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00396	0.0046	CcSEcCtD
Nadolol—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00393	0.00457	CcSEcCtD
Nadolol—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00393	0.00457	CcSEcCtD
Nadolol—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00389	0.00453	CcSEcCtD
Nadolol—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00389	0.00453	CcSEcCtD
Nadolol—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00389	0.00453	CcSEcCtD
Nadolol—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00389	0.00453	CcSEcCtD
Nadolol—ABCB1—Abacavir transport and metabolism—ABCG2—primary biliary cirrhosis	0.00367	0.0396	CbGpPWpGaD
Nadolol—Asthenia—Colchicine—primary biliary cirrhosis	0.00364	0.00423	CcSEcCtD
Nadolol—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0036	0.00419	CcSEcCtD
Nadolol—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0036	0.00419	CcSEcCtD
Nadolol—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00347	0.00403	CcSEcCtD
Nadolol—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00327	0.0038	CcSEcCtD
Nadolol—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00327	0.0038	CcSEcCtD
Nadolol—Vomiting—Colchicine—primary biliary cirrhosis	0.00322	0.00375	CcSEcCtD
Nadolol—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00322	0.00375	CcSEcCtD
Nadolol—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00322	0.00375	CcSEcCtD
Nadolol—Rash—Colchicine—primary biliary cirrhosis	0.0032	0.00372	CcSEcCtD
Nadolol—Dermatitis—Colchicine—primary biliary cirrhosis	0.00319	0.00371	CcSEcCtD
Nadolol—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00312	0.00362	CcSEcCtD
Nadolol—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00312	0.00362	CcSEcCtD
Nadolol—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00301	0.0035	CcSEcCtD
Nadolol—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00301	0.0035	CcSEcCtD
Nadolol—Nausea—Colchicine—primary biliary cirrhosis	0.00301	0.0035	CcSEcCtD
Nadolol—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.0029	0.00337	CcSEcCtD
Nadolol—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.0029	0.00337	CcSEcCtD
Nadolol—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00334	CcSEcCtD
Nadolol—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00334	CcSEcCtD
Nadolol—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00334	CcSEcCtD
Nadolol—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00334	CcSEcCtD
Nadolol—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00282	0.0305	CbGpPWpGaD
Nadolol—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00271	0.00315	CcSEcCtD
Nadolol—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00271	0.00315	CcSEcCtD
Nadolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00247	0.0267	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.00198	0.0214	CbGpPWpGaD
Nadolol—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.0017	0.0184	CbGpPWpGaD
Nadolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.00162	0.0175	CbGpPWpGaD
Nadolol—ABCB1—ABC-family proteins mediated transport—ABCC2—primary biliary cirrhosis	0.00155	0.0167	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.00132	0.0143	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.00117	0.0127	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.00115	0.0124	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.00113	0.0122	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.00105	0.0113	CbGpPWpGaD
Nadolol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—primary biliary cirrhosis	0.00103	0.0111	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.00103	0.0111	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.000953	0.0103	CbGpPWpGaD
Nadolol—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000945	0.0102	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.000927	0.01	CbGpPWpGaD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—primary biliary cirrhosis	0.00091	0.00983	CbGpPWpGaD
Nadolol—ADRB1—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000893	0.00965	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000861	0.0093	CbGpPWpGaD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—ABCG2—primary biliary cirrhosis	0.000811	0.00876	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000783	0.00846	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000782	0.00844	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000766	0.00827	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000671	0.00725	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000656	0.00709	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000609	0.00658	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000596	0.00644	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000588	0.00635	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.000582	0.00629	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.000547	0.00591	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000535	0.00577	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000511	0.00552	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.0005	0.0054	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000486	0.00525	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000464	0.00501	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.00046	0.00497	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000454	0.0049	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000442	0.00477	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000442	0.00477	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—CD40LG—primary biliary cirrhosis	0.000426	0.0046	CbGpPWpGaD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—HIF1A—primary biliary cirrhosis	0.000414	0.00447	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL4—primary biliary cirrhosis	0.000414	0.00447	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000407	0.0044	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000407	0.00439	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000401	0.00433	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000385	0.00416	CbGpPWpGaD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—NOS2—primary biliary cirrhosis	0.000377	0.00407	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.00035	0.00379	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000317	0.00343	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	0.000317	0.00342	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.00031	0.00335	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000293	0.00317	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000289	0.00312	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000282	0.00305	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000274	0.00296	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000273	0.00295	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000271	0.00293	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000267	0.00289	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000262	0.00283	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000262	0.00283	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000261	0.00282	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000256	0.00277	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000256	0.00277	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000242	0.00261	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000238	0.00257	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000237	0.00256	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000236	0.00255	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000233	0.00252	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.00023	0.00249	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000228	0.00247	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000224	0.00241	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000219	0.00237	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000209	0.00226	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000208	0.00225	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000203	0.0022	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000198	0.00214	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000191	0.00206	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—LBR—primary biliary cirrhosis	0.00019	0.00206	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.00018	0.00194	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000174	0.00188	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—AGT—primary biliary cirrhosis	0.00017	0.00184	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000169	0.00182	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000166	0.00179	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000162	0.00175	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000161	0.00174	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000157	0.0017	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000155	0.00167	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000152	0.00164	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—AGT—primary biliary cirrhosis	0.00015	0.00163	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000148	0.0016	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000141	0.00152	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	0.000138	0.00149	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000138	0.00149	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000138	0.00149	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000137	0.00148	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000134	0.00144	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.00013	0.00141	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000127	0.00138	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000124	0.00134	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000123	0.00133	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	0.000123	0.00133	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000121	0.00131	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000118	0.00127	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	0.000115	0.00125	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	0.000115	0.00125	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000115	0.00124	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000113	0.00122	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000113	0.00122	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—TYK2—primary biliary cirrhosis	0.000113	0.00122	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000111	0.0012	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000107	0.00115	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000106	0.00115	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000104	0.00113	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000103	0.00111	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	0.000103	0.00111	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—AGT—primary biliary cirrhosis	9.83e-05	0.00106	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—AGT—primary biliary cirrhosis	9.62e-05	0.00104	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—AGT—primary biliary cirrhosis	8.93e-05	0.000965	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HIF1A—primary biliary cirrhosis	8.92e-05	0.000964	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—AGT—primary biliary cirrhosis	8.89e-05	0.00096	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—AGT—primary biliary cirrhosis	8.73e-05	0.000944	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CD80—primary biliary cirrhosis	7.87e-05	0.00085	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.33e-05	0.000791	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.17e-05	0.000774	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	6.93e-05	0.000749	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MMP3—primary biliary cirrhosis	6.68e-05	0.000722	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—TYK2—primary biliary cirrhosis	6.68e-05	0.000721	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TYK2—primary biliary cirrhosis	6.65e-05	0.000718	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MMP3—primary biliary cirrhosis	6.54e-05	0.000706	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—TYK2—primary biliary cirrhosis	6.53e-05	0.000706	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	6.45e-05	0.000696	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL5—primary biliary cirrhosis	6.31e-05	0.000681	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL5—primary biliary cirrhosis	6.17e-05	0.000666	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.11e-05	0.00066	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	5.98e-05	0.000646	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	5.53e-05	0.000597	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	5.48e-05	0.000592	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	5.37e-05	0.00058	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.29e-05	0.000572	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AGT—primary biliary cirrhosis	5.27e-05	0.00057	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MMP9—primary biliary cirrhosis	5.23e-05	0.000565	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.18e-05	0.000559	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NFKB1—primary biliary cirrhosis	5.18e-05	0.000559	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AGT—primary biliary cirrhosis	5.16e-05	0.000557	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	4.73e-05	0.000511	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	4.73e-05	0.000511	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CD80—primary biliary cirrhosis	4.67e-05	0.000505	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CD80—primary biliary cirrhosis	4.57e-05	0.000494	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	4.21e-05	0.000455	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TYK2—primary biliary cirrhosis	3.94e-05	0.000426	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TYK2—primary biliary cirrhosis	3.86e-05	0.000417	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—AGT—primary biliary cirrhosis	3.28e-05	0.000354	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MMP9—primary biliary cirrhosis	3.11e-05	0.000336	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.07e-05	0.000332	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MMP9—primary biliary cirrhosis	3.04e-05	0.000328	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.01e-05	0.000325	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ALB—primary biliary cirrhosis	2.52e-05	0.000272	CbGpPWpGaD
